Jason Mraz co-founded and served as President of Ospraie Management in 1999 and was also a Managing Partner of Ospraie AG Science. In 2017, they co-founded and became a seed investor for Concarlo Therapeutics.
Jason Mraz did not attend Princeton University.
January, 2017 - present